Cargando…
6. Treatment resistant ulcerating dermatomyositis in metastatic melanoma treated with checkpoint inhibitor therapy
INTRODUCTION: Paraneoplastic dermatomyositis is a well-recognised clinical entity, and should prompt investigation for an underlying malignancy. Immunosuppressive treatment can be effective in control of both skin and muscle disease. The effect of checkpoint inhibitors for control of solid tumours o...
Autores principales: | Parker, Lucy, Coull, Philippa, Soliotis, Fotini |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6761471/ http://dx.doi.org/10.1093/rap/rkz030.005 |
Ejemplares similares
-
3. Dermatomyositis and underlying bilateral benign endometrioma
por: Parker, Lucy, et al.
Publicado: (2019) -
5. Isolated head drop: first symptom of anti-synthetase syndrome
por: Parker, Lucy, et al.
Publicado: (2019) -
Dermatomyositis Flare With Immune Checkpoint Inhibitor Therapy for Melanoma
por: Thomas, Rachel, et al.
Publicado: (2021) -
Predictors of toxicity for metastatic melanoma patients treated with ipilimumab
por: Valpione, Sara, et al.
Publicado: (2015) -
Pilot study of intratumoral (IT) cryoablation (cryo) in combination with systemic checkpoint blockade in patients with metastatic melanoma (MM)
por: Kim, Dae Won, et al.
Publicado: (2015)